BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26027950)

  • 1. Biocompatible Glycopolymer Nanocapsules via Inverse Miniemulsion Periphery RAFT Polymerization for the Delivery of Gemcitabine.
    Utama RH; Jiang Y; Zetterlund PB; Stenzel MH
    Biomacromolecules; 2015 Jul; 16(7):2144-56. PubMed ID: 26027950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced cellular uptake and intracellular drug controlled release of VESylated gemcitabine prodrug nanocapsules.
    Fang Y; Du F; Xu Y; Meng H; Huang J; Zhang X; Lu W; Liu S; Yu J
    Colloids Surf B Biointerfaces; 2015 Apr; 128():357-362. PubMed ID: 25746328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aqueous-core PEG-coated PLA nanocapsules for an efficient entrapment of water soluble anticancer drugs and a smart therapeutic response.
    Cosco D; Paolino D; De Angelis F; Cilurzo F; Celia C; Di Marzio L; Russo D; Tsapis N; Fattal E; Fresta M
    Eur J Pharm Biopharm; 2015 Jan; 89():30-9. PubMed ID: 25460850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of pH-Responsive Nanocapsules via Inverse Miniemulsion Periphery RAFT Polymerization and Post-Polymerization Reaction.
    Utama RH; Drechsler M; Förster S; Zetterlund PB; Stenzel MH
    ACS Macro Lett; 2014 Sep; 3(9):935-939. PubMed ID: 35596363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemcitabine-loaded biocompatible nanocapsules for the effective treatment of human cancer.
    Paolino D; Cosco D; Celano M; Moretti S; Puxeddu E; Russo D; Fresta M
    Nanomedicine (Lond); 2013 Feb; 8(2):193-201. PubMed ID: 23094834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation, physicochemical characterization and cytotoxicity in vitro of gemcitabine-loaded PEG-PDLLA nanovesicles.
    Jia L; Zheng JJ; Jiang SM; Huang KH
    World J Gastroenterol; 2010 Feb; 16(8):1008-13. PubMed ID: 20180242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SAXS Analysis of Shell Formation During Nanocapsule Synthesis via Inverse Miniemulsion Periphery RAFT Polymerization.
    Utama RH; Dulle M; Förster S; Stenzel MH; Zetterlund PB
    Macromol Rapid Commun; 2015 Jul; 36(13):1267-71. PubMed ID: 25882373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate-targeted supramolecular vesicular aggregates based on polyaspartyl-hydrazide copolymers for the selective delivery of antitumoral drugs.
    Licciardi M; Paolino D; Celia C; Giammona G; Cavallaro G; Fresta M
    Biomaterials; 2010 Oct; 31(28):7340-54. PubMed ID: 20609469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of Pancreatic Cancer Therapy Efficacy by Type-1 Matrix Metalloproteinase-Functionalized Nanoparticles for the Selective Delivery of Gemcitabine and Erlotinib.
    Yin N; Yu H; Zhang X; Lv X
    Drug Des Devel Ther; 2020; 14():4465-4475. PubMed ID: 33122890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micellar nanoparticles loaded with gemcitabine and doxorubicin showed synergistic effect.
    Liu D; Chen Y; Feng X; Deng M; Xie G; Wang J; Zhang L; Liu Q; Yuan P
    Colloids Surf B Biointerfaces; 2014 Jan; 113():158-68. PubMed ID: 24077114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encapsulation of gemcitabine lipophilic derivatives into polycyanoacrylate nanospheres and nanocapsules.
    Stella B; Arpicco S; Rocco F; Marsaud V; Renoir JM; Cattel L; Couvreur P
    Int J Pharm; 2007 Nov; 344(1-2):71-7. PubMed ID: 17651931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sonochemical preparation of folate-decorated reductive-responsive carboxymethylcellulose-based nanocapsules for targeted drug delivery.
    He S; Zhong S; Meng Q; Fang Y; Dou Y; Gao Y; Cui X
    Carbohydr Polym; 2021 Aug; 266():118174. PubMed ID: 34044962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo anti-tumor effects of gemcitabine loaded with a new drug delivery system.
    Tong Q; Li H; Li W; Chen H; Shu X; Lu X; Wang G
    J Nanosci Nanotechnol; 2011 Apr; 11(4):3651-8. PubMed ID: 21776750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An innovative hydrogel of gemcitabine-loaded lipid nanocapsules: when the drug is a key player of the nanomedicine structure.
    Moysan E; González-Fernández Y; Lautram N; Béjaud J; Bastiat G; Benoit JP
    Soft Matter; 2014 Mar; 10(11):1767-77. PubMed ID: 24652455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione Responsive Hyaluronic Acid Nanocapsules Obtained by Bioorthogonal Interfacial "Click" Reaction.
    Baier G; Fichter M; Kreyes A; Klein K; Mailänder V; Gehring S; Landfester K
    Biomacromolecules; 2016 Jan; 17(1):148-53. PubMed ID: 26629829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural polysaccharide functionalized gold nanoparticles as biocompatible drug delivery carrier.
    Pooja D; Panyaram S; Kulhari H; Reddy B; Rachamalla SS; Sistla R
    Int J Biol Macromol; 2015 Sep; 80():48-56. PubMed ID: 26093321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A biocompatible and cathepsin B sensitive nanoscale system of dendritic polyHPMA-gemcitabine prodrug enhances antitumor activity markedly.
    Dai Y; Ma X; Zhang Y; Chen K; Tang JZ; Gong Q; Luo K
    Biomater Sci; 2018 Nov; 6(11):2976-2986. PubMed ID: 30255871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-targeted polymeric nanostructured lipid carriers with precise ratiometric control over dual-drug loading for combination therapy in non-small-cell lung cancer.
    Liang Y; Tian B; Zhang J; Li K; Wang L; Han J; Wu Z
    Int J Nanomedicine; 2017; 12():1699-1715. PubMed ID: 28280336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of gemcitabine hydrochloride loaded lipid polymer hybrid nanoparticles (LPHNs): In vitro and in vivo.
    Yalcin TE; Ilbasmis-Tamer S; Takka S
    Int J Pharm; 2020 Apr; 580():119246. PubMed ID: 32205141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic RGDfK Peptide Functionalized Polymeric Nanocarriers for Targeting Gemcitabine to Ovarian Cancer Cells.
    Kulhari H; Pooja D; Kota R; Reddy TS; Tabor RF; Shukla R; Adams DJ; Sistla R; Bansal V
    Mol Pharm; 2016 May; 13(5):1491-500. PubMed ID: 26930230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.